EMEA-001055-PIP01-10
Key facts
| Active substance |
|
| Therapeutic area |
Oncology
|
| Decision number |
P/61/2011
|
| PIP number |
EMEA-001055-PIP01-10
|
| Pharmaceutical form(s) |
Powder for suspension for injection
|
| Condition(s) / indication(s) |
Treatment of vulvar intraepithelial neoplasia
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
ISA Therapeutics BV
info@isa-pharma.com
The Netherlands +31 713322310 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|